AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...

Discover AngioDynamics' Q3 2025 performance milestones, with 9% YoY growth, NanoKnife adoption, and expanded guidance.

Good morning and welcome to the AngioDynamics fiscal year 20,253 quarter earnings call. (Operator Instructions) As a reminder, this conference call is being recorded. The news released detailing ...

The global market for MRI-guided and focused ultrasound devices is on the cusp of substantial growth, driven by technological innovations and an increasing preference for non-invasive therapeutic ...

FALCON: A Consensus to guide the future of focal therapy. FALCON aims to provide clear guidance for partial gland ablation in prostate cancer (PCa). After more than 30 years of research, focal therapy ...

Objectives: The aim of this work was to review the available evidence on transperineal focal laser ablation (FLA) for patients with ... Transperineal FLA for the treatment of clinically localized ...

Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) are purchasing and donating two Histotripsy Systems to the National Cancer Centre Singapore (NCCS) and the National University Cancer Institute, ...

Pulmonary-vein isolation is an effective treatment for paroxysmal atrial fibrillation. Pulsed field ablation (PFA) is a nonthermal ablation method with few adverse effects beyond the myocardium.